Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-844P is designated as a pseudogene for the U6 small nuclear RNA gene family. Pseudogenes are genomic DNA sequences similar to functional genes but are generally non-expressed and do not produce functional RNA or protein products. The U6 small nuclear RNA itself is highly conserved and vital for spliceosome activity, facilitating the excision of introns from pre-mRNA in eukaryotes[1][3]. However, RNU6-844P and similar U6-derived pseudogenes are considered evolutionary remnants with no known functional or disease-related role[2][4][5]. They do not participate in molecular pathways, do not serve as biomarkers or therapeutic targets, and are not associated with known safety or pharmacological issues. Their presence reflects genomic duplication and evolution, not active cellular function. If seeking a therapeutic target, the functional gene U6 small nuclear RNA (RNU6-1 or related loci) would be relevant, but not the RNU6-844P pseudogene[1][3][4].
No mechanism; does not encode a druggable or functional target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 844, pseudogene (RNU6-844P).